Get started
Work

Pan-tumor harmonization of pathologic response assessment for standardized data collection in neoadjuvant trials (PATHdata): results of a Society for Immunotherapy of Cancer multi-institutional reproducibility study

Year: 2026
Type: article
DOI: 10.1016/j.annonc.2026.01.011
Authors: J.S. Deutsch, T.R. Cottrell, K.Y. Chen, C.E. De Andrea, E. Baraban, P.O. Fiset, J.J. Jedrych, C.E. Orr, F.X. Real, R. Salgado, C.M. Schürch, R.A. Scolyer, R. Seethala, L.M. Sholl, S. Signoretti, M. Tetzlaff, H. Wang, T. Wang, A. Weissferdt, X. Xu, J. Ziai, A. Cimino-Mathews, J.M. Taube
Institutions: Johns Hopkins University, Queen's University, Universidad de Navarra, McGill University Health Centre, Spanish National Cancer Research Centre, Peter MacCallum Cancer Centre, Ziekenhuis aan de Stroom, Peter MacCallum Cancer Foundation, University of Tübingen, The University of Sydney, Royal Prince Alfred Hospital, Melanoma Institute Australia, NSW Health Pathology, University of Pittsburgh Medical Center, Brigham and Women's Hospital, University of California, San Francisco, Sidney Kimmel Comprehensive Cancer Center, The University of Texas MD Anderson Cancer Center, Abramson Cancer Center, University of Pennsylvania, Genentech
Language: English
Open Access status: closed
Funders: Dermatology Foundation, LUNGevity Foundation, Melanoma Research Alliance, Ontario Institute for Cancer Research, Mark Foundation For Cancer Research, National Institutes of Health, National Cancer Institute, Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
OpenAlex ID: W7127075453
FWCI: 24.78
Cites: 45
Cited by: 5
Related to: